🔎 Trials Near Me

Home › Crohn's Disease › Connecticut › New Haven

Crohn's Disease clinical trials in New Haven, CT

8 studies for Crohn's Disease are looking for participants at sites in and around New Haven (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

RecruitingPhase 3
  • Medical Research Center of Connecticut, Hamden · 6 mi away
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07499232

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

RecruitingPhase 2
  • Yale University School of Medicine /ID# 266786, New Haven
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT06548542

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

RecruitingPhase 3
  • Yale University Digestive Disease-Site Number: 8400108, New Haven
Ages 16 to 80 · All sexes · Updated Sep 23, 2026 · NCT07184931

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

RecruitingPhase 1
  • Smilow Cancer Center/Yale-New Haven Hospital, New Haven
  • Yale University, New Haven
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

RecruitingPhase 3
  • Yale University School of Medicine-Digestive Disease ( Site 5019), New Haven
Ages 16 to 80 · All sexes · Updated Sep 17, 2026 · NCT06430801

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

RecruitingPhase 4
  • Medical Research Center of Connecticut, LLC, Hamden · 6 mi away
Ages 18 to 70 · All sexes · Updated Sep 9, 2026 · NCT06045754

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Recruiting
  • Yale University, New Haven
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT05230173

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

RecruitingObservational study
  • Yale University School of Medicine, New Haven
Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT07237516

About Crohn's Disease

Crohn's Disease can cause inflammation in any area from the mouth to the anus. Read about medicines, surgery or dietary management to treat symptoms.

More about Crohn's Disease on MedlinePlus

Crohn's Disease trials in other cities

Other studies in New Haven

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.